|1.||Roberts, Ian: 7 articles (01/2013 - 01/2005)|
|2.||Koyama, Takatoshi: 4 articles (01/2010 - 07/2002)|
|3.||Shakur, Haleema: 4 articles (01/2010 - 01/2005)|
|4.||Shapiro, A D: 3 articles (05/2014 - 01/2003)|
|5.||Perel, Pablo: 3 articles (01/2013 - 01/2007)|
|6.||Mazer, C David: 3 articles (01/2012 - 05/2007)|
|7.||Bisoi, Akshay: 3 articles (04/2004 - 08/2003)|
|8.||Chauhan, Sandeep: 3 articles (04/2004 - 08/2003)|
|9.||Huncke, Tessa: 2 articles (04/2015 - 05/2014)|
|10.||Hoelscher, Christian: 2 articles (04/2015 - 05/2014)|
10/01/1986 - "It is important to recognize excessive fibrinolysis as the underlying cause of bleeding in these patients, since specific treatment with antifibrinolytic agents is effective in controlling the bleeding."
11/01/2012 - "The systemic or topical use of antifibrinolytic agents is effective in reducing postoperative bleeding and blood product transfusion in cardiac surgery. "
04/01/2001 - "They commonly lead to increased intraoperative bleeding, especially due to increased fibrinolysis, the contribution of which can be demonstrated by the relative efficacy of antifibrinolytics. "
05/01/2013 - "Evidence from two studies of fair to poor quality suggested that antifibrinolytic agents might be helpful in preventing heavy or prolonged menstrual bleeding among new Cu-IUD users. "
11/01/1994 - "A majority of published studies confirm the efficacy of antifibrinolytics administered prophylactically to reduce postoperative bleeding and transfusion of HBP. "
07/01/1987 - "Systemic administration of antifibrinolytic agents and non-steroidal anti-inflammatory drugs hold promise for the control of IUD-induced menorrhagia. "
05/13/2013 - "Treatment of menorrhagia with antifibrinolytics is a well documented treatment modality and it is considered safe although thromboembolic complications have been reported. "
02/01/2011 - "Antifibrinolytics in women with menorrhagia."
07/01/1987 - " Systemic administration of antifibrinolytic agents and nonsteroidal anti-inflammatory drugs have potential for the control of IUD-induced menorrhagia. "
11/01/1982 - "Antifibrinolytic agents when released into the uterine cavity decrease menorrhagia associated with IUD use. "
05/21/2014 - "The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial."
01/01/2015 - "We conducted a systematic review and meta-analysis for randomized controlled trials (RCTs), retrospective case-control studies, and retrospective cohort studies on the use of antifibrinolytic agents in scoliosis surgery by searching in the MEDLINE and EMBASE databases and the Cochrane Database of Systematic Reviews and Controlled Trials of papers published from January 1980 through July 2014. "
01/01/2008 - "We included blinded or unblinded randomized controlled trials that evaluated the effect of antifibrinolytics on perioperative blood loss in children that were 18 years of age or younger and undergoing scoliosis surgery. "
01/01/2015 - "Efficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-Analysis."
01/01/2008 - "Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children."
01/01/1990 - "Although anecdotal reports have fueled fears of increased thrombosis with antifibrinolytics, controlled studies indicate no increased risk."
12/01/2011 - "The patient hemorrhaged after a sternal closure and required transfusions and antifibrinolytics that led to thrombus in the membrane and membrane circuitry, which were replaced without incident. "
06/01/2009 - "Prophylaxis with antifibrinolytics is being questioned for the risk of thrombosis. "
03/01/2000 - "Thrombosis is a rare complication of APL and may be due to the alterations in hemostasis caused by the disease itself as well as ATRA and antifibrinolytics. "
01/01/1978 - "Determination of fast-acting plasmin inhibitor (alpha2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis."
|5.||Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/01/2014 - "Are antifibrinolytic agents effective in the treatment of aneurysmal subarachnoid hemorrhage?"
01/01/2012 - "To reassess the use of antifibrinolytics (AF) in the management of aneurysmal subarachnoid hemorrhage (SAH) in the setting of present-day treatment strategies. "
11/01/1989 - "We prospectively studied 244 consecutive patients with subarachnoid hemorrhage who were admitted within 72 hours to the same institution between November 1977 and May 1987 and who were not treated with antifibrinolytics. "
01/01/1987 - "[Intrathecal administration of antifibrinolytics in primary subarachnoid hemorrhage during the acute period]."
01/01/1987 - "Antifibrinolytics in subarachnoid hemorrhage."
|1.||Tranexamic Acid (AMCA)
|2.||recombinant FVIIa (rFVIIa)
|4.||Deamino Arginine Vasopressin (Desmopressin)
|5.||Levonorgestrel (Plan B)
|6.||prothrombin complex concentrates (PPSB)
|7.||alpha-2-Antiplasmin (alpha 2 Antiplasmin)
|9.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
|1.||Blood Transfusion (Blood Transfusions)
|2.||Platelet Transfusion (Blood Platelet Transfusions)